Immunome, Inc. (IMNM) Operating margin 2023–2025
Immunome, Inc. (IMNM) operating margin by fiscal year — reported operating income divided by reported revenue.
-3228.8%FY2025 · since FY2023: -781.4% → -3228.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3228.8% | +153.5 pp |
| FY2024 | -3382.4% | -2601.0 pp |
| FY2023 | -781.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice